Skip to main navigation menu Skip to main content Skip to site footer

Saggi, Studi e Ricerche

No. 49 (2018)

How to drive health services towards a safe and efficient model for pain treating with opioid drugs: an observational study in the sentence prison of Padua

Submitted
ottobre 23, 2017
Published
2018-02-22

Abstract

In prison pain assumes a disproportionate magnitude and it is not generally adequately treated. The reasons are often due to the fear to prescribe to detainees opioid analgesic agents for the risk of misuse and diversion. The purpose of this observational study, carried out on 598 detainees in the sentence prison of Padua, was to identify the obstacles and barriers to the use opioid analgesic drugs for pain management and to find recommendations for their implementation and rational use.The study showed an inappropriate prescription of analgesic drugs and misuse and diversion phenomena, especially in detained drug users. Recommendations, procedures and guidelines for the pain treatment should be adopted in all prisons.


References

  1. Adams L.L., Gatchel R.J., Robinson R.C., Polatin P., Gajraj N., Deschner M., Noe C. (2004). Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. Journal of Pain and Symptom Management, 27(5): 440-59. doi: 10.1016/j.jpainsymman.2003.10.009.
  2. Alexander L., Mannion R.O., Weingarten B., Fanelli R.J., Stiles G.L. (2014). Development and impact of prescription opioid abuse deterrent formulation technologies. Drug and Alcohol Dependence, 138: 1-6. doi: 10.1016/j.drugalcdep.2014.02.006.
  3. Breivik H., Collett B., Ventafridda V., Cohen R., Gallacher D. (2006). Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. European Journal of Pain (London, England), 10(4): 287-333. doi: 10.1016/j.ejpain.2005.06.009.
  4. Chou R., Fanciullo G.J., Fine P.G., Adler J.A., Ballantyne J.C., Davies P., … Miaskowski C. (2009). Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain. Journal of Pain, 10(2). doi: 10.1016/j.jpain.2008.10.008.
  5. Croft M., Mayhew R. (2015). Prevalence of chronic non-cancer pain in a UK prison environment. British Journal of Pain, 9(2): 96-108. doi:10.1177/2049463714540895.
  6. Davis C.S., Carr D. (2016). Physician continuing education to reduce opioid misuse, abuse, and overdose: Many opportunities, few requirements. Drug and Alcohol Dependence, 163: 100-7. doi: 10.1016/j.drugalcdep.2016.04.002.
  7. Department of Health (2007). Clinical Management of Drug Dependence in the Adult Prison Setting Including Psychosocial Treatment as a Core Part.
  8. Eccleston C., Fisher E., Craig L., Duggan G.B., Rosser B.A., Keogh E. (2014). Psychological therapies (Internet-delivered) for the management of chronic pain in adults. The Cochrane Database of Systematic Reviews, (2), CD010152. doi: 10.1002/14651858.CD010152.pub2.
  9. Fazel S., Hope T., O’Donnell I., Jacoby R. (2001). Hidden psychiatric morbidity in elderly prisoners. The British Journal of Psychiatry?: The Journal of Mental Science, 179(6): 535-9. doi: 10.1192/bjp.179.6.535.
  10. Griffin M.L., McDermott K.A., McHugh R.K., Fitzmaurice G.M., Jamison R.N., Weiss R.D. (2016). Longitudinal association between pain severity and subsequent opioid use in prescription opioid dependent patients with chronic pain. Drug and Alcohol Dependence, 163: 216-221. doi: 10.1016/j.drugalcdep.2016.04.023.
  11. Levy M. (2012). Safer prescribing for prisoners. BMJ (Clinical Research Ed.), 344, e447. -- Retrieved from www.ncbi.nlm.nih.gov/pubmed/22282531.
  12. Martel M.O., Finan P.H., McHugh R.K., Issa M., Edwards R.R., Jamison R.N., Wasan A.D. (2016). Day-to-day pain symptoms are only weakly associated with opioid craving among patients with chronic pain prescribed opioid therapy. Drug and Alcohol Dependence, 162: 130-6. doi: 10.1016/j.drugalcdep.2016.02.047.
  13. NHS (2015a). Pain Management Formulary for Prisons: Implementation Guide.
  14. NHS (2015b). Pain Management Formulary for Prisons: The Formulary for acute, persistent and neuropathic pain.
  15. Public Health England (2013). Managing persistent pain in secure settings.
  16. Reid K.J., Harker J., Bala M.M., Truyers C., Kellen E., Bekkering G.E., Kleijnen J. (2011). Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact. Current Medical Research and Opinion, 27(2): 449-62. doi: 10.1185/03007995.2010.545813.
  17. Singleton N., Bumpstead R., O’Brien M., Lee A., Meltzer H. (1998). Psychiatric morbidity among adults living in private households, 2000. London: Office for NationalStatistics, 1-164. -- Retrieved from file:///C:/Users/hp/Downloads/psychmorb_tcm77-144477.pdf.
  18. Solanki D.R., Koyyalagunta D., Shah R.V., Silverman S.M., Manchikanti L. (2011). Monitoring opioid adherence in chronic pain patients: assessment of risk of substance misuse. Pain Physician, 14(2): E119-31. -- Retrieved from www.ncbi.nlm.nih.gov/pubmed/21412377.
  19. Turk D.C., Swanson K.S., Gatchel R.J. (n.d.). Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. The Clinical Journal of Pain, 24(6): 497-508. DOI: 10.1097/AJP.0b013e31816b1070.
  20. Wasan A.D., Butler S.F., Budman S.H., Fernandez K., Weiss R.D., Greenfield S.F., Jamison R.N. (2009). Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? The Clinical Journal of Pain, 25(3): 193-8. doi: 10.1097/AJP.0b013e318193a6c4.

Metrics

Metrics Loading ...